February 6th 2020 There are many reasons a treatment might not be available for patients, but this one from a recommendation by a UK National Health Service (NHS) watchdog shocked us: the £10,000 cost for the treatment is too high to make available to patients with severe depression that might benefit from it!?!?!? Typically where … Continue reading Ketamine antidepressant spray treatment not available for patients…because of cost?
The animal research behind the new nasal spray depression treatment
Or, our tax dollars at work! Last week, the FDA approved a new drug for treatment-resistant depression (TRD). The nasal spray version of the drug ketamine, called Spravato (esketamine), is a newly-approved, fast-acting drug, available only with a doctor’s prescription, that could help millions. Did you know that a wide range of nonhuman animal research … Continue reading The animal research behind the new nasal spray depression treatment
A Noble cause: Protecting babies brains with Xenon
Back in October I wrote about how animal research has enabled the development of brain cooling as a treatment to reduce brain damage in babies who had suffered oxygen starvation during birth. This is a problem that affects tens of thousands of babies every year, and frequently results in death or long-term disability. Brain cooling … Continue reading A Noble cause: Protecting babies brains with Xenon